Fermenta Biotech Intrinsic Value
Fermenta Biotech (FERMENTA) median intrinsic value is ₹580.00 from 9 valuation models (range ₹171–₹864), vs current price ₹432.05 — +34.2% upside (Trading Below Calculated Value), margin of safety 25.5%. For current market price and key ratios, visit Fermenta Biotech screener.
FERMENTA Valuation Methods Summary — DCF, Graham Number & P/E
Fermenta Biotech intrinsic value across 9 models vs current price ₹432.05 — upside/downside and value range per method. Analyse FERMENTA FII DII holdings to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹586.08 | ₹468.86 - ₹703.30 | +35.7% | EPS: ₹26.64, Sector P/E: 22x |
| Book Value Method | asset | ₹580.00 | ₹522.00 - ₹638.00 | +34.2% | Book Value/Share: ₹290.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹777.14 | ₹699.43 - ₹854.85 | +79.9% | Revenue/Share: ₹388.57, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹864.10 | ₹777.69 - ₹950.51 | +100.0% | EBITDA: ₹136.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹271.88 | ₹217.50 - ₹326.26 | -37.1% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹170.50 | ₹153.45 - ₹187.55 | -60.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹411.59 | ₹370.43 - ₹452.75 | -4.7% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹760.00 | ₹684.00 - ₹836.00 | +75.9% | ROE: 18.7%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹416.92 | ₹375.23 - ₹458.61 | -3.5% | EPS: ₹26.64, BVPS: ₹290.00 |
FERMENTA Intrinsic Value vs Market Price — All Valuation Models
Fermenta Biotech fair value range ₹171–₹864 vs current market price ₹432.05 across 9 valuation models. Read FERMENTA dividend history for the complete payout history and dividend yield track record.
FERMENTA Intrinsic Value Analysis — Undervalued or Overvalued?
Fermenta Biotech median intrinsic value ₹580.00, current price ₹432.05 — Trading Below Calculated Value by 34.2%, margin of safety 25.5%.
What is the intrinsic value of FERMENTA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Fermenta Biotech (FERMENTA) is ₹580.00 (median value). With the current market price of ₹432.05, this represents a +34.2% variance from our estimated fair value.
The valuation range spans from ₹170.50 to ₹864.10, indicating ₹170.50 - ₹864.10.
Is FERMENTA undervalued or overvalued?
Based on our multi-method analysis, Fermenta Biotech (FERMENTA) appears to be trading below calculated value by approximately 34.2%.
FERMENTA Financial Health — Key Ratios vs Industry Benchmarks
Fermenta Biotech financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.95 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 18.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.84x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
FERMENTA Cash Flow Quality — Operating & Free Cash Flow
Fermenta Biotech operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹41 Cr | ₹41 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹105 Cr | ₹97 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹116 Cr | ₹89 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹43 Cr | ₹30 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹63 Cr | ₹43 Cr | Positive Free Cash Flow | 8/10 |